Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,991 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.
Shimagaki T, Yoshio S, Kawai H, Sakamoto Y, Doi H, Matsuda M, Mori T, Osawa Y, Fukai M, Yoshida T, Ma Y, Akita T, Tanaka J, Taketomi A, Hanayama R, Yoshizumi T, Mori M, Kanto T. Shimagaki T, et al. Among authors: mori m, mori t. Sci Rep. 2019 Oct 31;9(1):15788. doi: 10.1038/s41598-019-52356-6. Sci Rep. 2019. PMID: 31673081 Free PMC article. Clinical Trial.
[Immune Response on Outcomes in Hepatocellular Carcinoma].
Iseda N, Itoh S, Tomiyama T, Morinaga A, Wang H, Shimagaki T, Kurihara T, Nagao Y, Toshima T, Harada N, Iguchi T, Yoshizumi T, Mori M. Iseda N, et al. Among authors: mori m. Gan To Kagaku Ryoho. 2020 Sep;47(9):1303-1306. Gan To Kagaku Ryoho. 2020. PMID: 33130688 Japanese.
Myostatin as a fibroblast-activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma.
Yoshio S, Shimagaki T, Hashida R, Kawaguchi T, Tsutsui Y, Sakamoto Y, Yoshida Y, Kawai H, Yoshikawa S, Yamazoe T, Mori T, Osawa Y, Itoh S, Fukai M, Yoshizumi T, Taketomi A, Mori M, Kanto T. Yoshio S, et al. Among authors: mori m, mori t. Hepatol Res. 2021 Jul;51(7):803-812. doi: 10.1111/hepr.13667. Epub 2021 May 25. Hepatol Res. 2021. PMID: 33998102
Impact of Nuclear Factor Erythroid 2-Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status.
Iseda N, Itoh S, Yoshizumi T, Tomiyama T, Morinaga A, Yugawa K, Shimokawa M, Shimagaki T, Wang H, Kurihara T, Kitamura Y, Nagao Y, Toshima T, Harada N, Kohashi K, Baba S, Ishigami K, Oda Y, Mori M. Iseda N, et al. Among authors: mori m. Hepatol Commun. 2022 Apr;6(4):665-678. doi: 10.1002/hep4.1838. Epub 2021 Oct 23. Hepatol Commun. 2022. PMID: 34687175 Free PMC article.
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma.
Tomimaru Y, Eguchi H, Nagano H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Tomokuni A, Takemasa I, Umeshita K, Kanto T, Doki Y, Mori M. Tomimaru Y, et al. Among authors: mori m. J Hepatol. 2012 Jan;56(1):167-75. doi: 10.1016/j.jhep.2011.04.026. Epub 2011 Jul 13. J Hepatol. 2012. PMID: 21749846
9,991 results